Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2
Ret/ptc2 is a constitutively active, oncogenic form of the c-Ret receptor tyrosine kinase. Like the other papillary thyroid carcinoma forms of Ret, Ret/ptc2 is activated through fusion of the Ret tyrosine kinase domain to the dimerization domain of another protein. Investigation of requirements for...
Na minha lista:
| Publicado no: | Mol Cell Biol |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
1998
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC121481/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9528800/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.18.4.2298 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|